Oxford BioDynamics Plc (OXBOF) Financials

OXBOF Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 10.9 million 9.4 million
March 31, 2025 17.2 million 9.5 million
Sept. 30, 2024 16.2 million 10.4 million
March 31, 2024 14.0 million 11.9 million

OXBOF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -3.7 million ?
March 31, 2025 -6.3 million 208317
Sept. 30, 2024 -9.7 million 286235
March 31, 2024 -4.5 million 379103

OXBOF Net Income

No data available :(

OXBOF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 1.9 million - 6.9 million
March 31, 2025 5.5 million - 6.7 million
Sept. 30, 2024 3.8 million - 7.7 million
March 31, 2024 1.5 million - 7.6 million

OXBOF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 1.5 billion
March 31, 2025 1.1 billion
Sept. 30, 2024 342.1 million
March 31, 2024 255.6 million

OXBOF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 22834 275362 2.1 million -
March 31, 2025 - 568020 6.7 million 3.6 million
Sept. 30, 2024 707564 616611 -1.3 million -4.4 million
March 31, 2024 83402 439760 6.9 million 4.1 million

OXBOF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 682901 392533
March 31, 2025 759516 363584
Sept. 30, 2024 413303 205982
March 31, 2024 413223 243890

OXBOF

Price: $0

52 week price:
0.00
0.01

Earnings Per Share: -0.01 USD

Exchange: PNK

Sector: Healthcare

Industry: Diagnostics & Research

Market Capitalization: 4.3 million

Links: